GlassScriptPhysician profile
Danielle Lalanne
NPI 1578138590
$636.33
in general payments reported to CMS, 2019-2025
15 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.38 · 2023: $208 · 2024: $199 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $119.23 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $104.58 | 2022-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $101.15 | 2023-2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $65.48 | 2024-2025 | Ycanth |
| Sobi, INC | $33.93 | 2023 | |
| Seqirus USA INC | $30.12 | 2024 | Flucelvax |
| Aytu Biopharma, INC. | $27.58 | 2024-2025 | Karbinal |
| Pfizer INC. | $26.62 | 2025 | |
| Corium, LLC | $22.00 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $20.76 | 2023 | Bexsero, Pediarix |
| Ironshore Pharmaceuticals INC. | $20.05 | 2023 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $20.01 | 2025 | Neffy |
| Lnhc, INC | $16.80 | 2025 | Zelsuvmi |
| Alk-Abello, INC | $14.29 | 2025 | Neffy |
| Cumberland Pharmaceuticals, INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Lalanne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.